Volume 11, Issue 1 (Winter 2022)                   JOHE 2022, 11(1): 1-9 | Back to browse issues page

XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Hashemipour E, Vazirinejad R, Sheikh Fatholahi M, Rezaian M. The Survival Rate of Patients with Colorectal Cancer in Kerman Province of Iran from 2007 to 2016. JOHE. 2022; 11 (1) :1-9
URL: http://johe.rums.ac.ir/article-1-460-en.html
1- MSc in Epidemiology, Dept. of Epidemiology and Biostatistics, School of Medicine, Rafsanjan University of Medical Sciences, Rafsanjan, Iran.
2- Professor, Social Determinants of Health Research Center, Rafsanjan University of Medical Sciences, Rafsanjan, Iran.
3- Assistant Prof., of Biostatistics, Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran.
4- Professor, Head of Dept. of Epidemiology and Biostatistics, Occupational Environmental Research Center, School of Medicine, Rafsanjan University of Medical Sciences, Rafsanjan, Iran. , moeygmr2@yahoo.co.uk
Abstract:   (74 Views)

Background: This paper presents the conditional relative survival rates of colorectal cancer (CRC) and associated prognostic factors in the Kerman province, the largest province in the south of Iran. Scince CRC is the fifth common cancer in this province, this study aimed to provide more detailed statistics on the survival rate of CRC patients.
Materials and Methods: This survival analysis study used the national population-based cancer registry data to estimate the survival rate in 1705 patients with CRC from 2007 to 2016. The Kaplan–Meier estimator and Log-rank test were used to plot survival curves and assess differences in survival rates. Univariate analysis and Cox proportional-hazards model were also used to determine association between CRC-related factors and patient survival.
Results: The 5-year survival rate for patients with CRC was 51.9%. This rate was significantly higher in the stage with localized lesions compared with those of regional and distant (p<0.001). The survival rate in patients undergoing surgical treatment was higher than that of patients receiving chemotherapy (p<0.001). Increased age, low tumor differentiation, the stage with distant tumors, and right-sided colon cancer (RCC) were associated with lower survival (p<0.001).
Conclusions: The tumor stage was significantly correlated with the survival rate of patients. Despite advances in the diagnosis and treatment of CRC in Iran and worldwide, the survival rate of patients in this study was low. Since many factors affect this rate, further studies are needed to identify its prognostic factors in Kerman

Article number: 1
Full-Text [PDF 604 kb]   (40 Downloads)    
Short Report: Original Article | Subject: Epidemiology
Received: 2021/08/15 | Accepted: 2022/01/22 | ePublished: 2022/06/12

References
1. 1- Arnold M, Sierra MS, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global patterns and trends in colorectal cancer incidence and mortality. Gut 2017; 66(4):683-91. [DOI] [PMID]
2. 2- Cronin KA, Lake AJ, Scott S, Sherman RL, Noone AM, Howlader N, et al. Annual Report to the Nation on the Status of Cancer, part I: National cancer statistics. Cancer 2018; 124(13):2785-800. [DOI] [PMID] [PMCID]
3. 3- Siegel RL, Miller KD, Goding Sauer A, Fedewa SA, Butterly LF, Anderson JC, et al. Colorectal cancer statistics, 2020. CA Cancer J Clin 2020; 70(3):145-64. [DOI] [PMID]
4. 4- Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 2015; 136(5):E359-86. [DOI] [PMID]
5. 5- Vos T, Lim SS, Abbafati C, Abbas KM, Abbasi M, Abbasifard M, et al. Global burden of 369 diseases and injuries in 204 countries and 417 territories, 1990–2019: a systematic analysis for the global burden of Disease Study 2019. Lancet 2020; 396(10258):1204-22. [DOI]
6. 6- Roshandel G, Ghanbari-Motlagh A, Partovipour E, Salavati F, Hasanpour-Heidari S, Mohammadi G, et al. Cancer incidence in Iran in 2014: Results of the Iranian National Population-based Cancer Registry. Cancer Epidemiol 2019; 61:50-8. [DOI] [PMID]
7. 7- Miller KD, Nogueira L, Mariotto AB, Rowland JH, Yabroff KR, Alfano CM, et al. Cancer treatment and survivorship statistics, 2019. CA Cancer J Clin 2019; 69(5):363-85. [DOI] [PMID]
8. 8- Jeffery M, Hickey BE, Hider PN. Follow‐up strategies for patients treated for non‐metastatic colorectal cancer. Cochrane Database Syst Rev 2019; 9(9):CD002200. [DOI] [PMID] [PMCID]
9. 9- US Preventive Services Task Force, Bibbins-Domingo K, Grossman DC, Curry SJ, Davidson KW, Epling JW, et al. Screening for Colorectal Cancer: US Preventive Services Task Force Recommendation Statement. JAMA 2016; 315(23):2564-75. [DOI] [PMID]
10. 10- Ahmed S, Leis A, Fields A, Chandra-Kanthan S, Haider K, Alvi R, et al. Survival Impact of Surgical Resection of Primary Tumor in Patients With Stage IV Colorectal Cancer: Results From a Large Population-Based Cohort Study. Cancer 2014; 120(5):683-91. [DOI] [PMID]
11. 11- Keyghobadi N, Rafiemanesh H, Mohammadian A, Enayatrad M, Salehiniya H. Epidemiology and Trend of Cancers in the Province of Kerman: Southeast of Iran. Asian Pac J Cancer Prev 2015; 16(4):1409-13. [DOI] [PMID]
12. 12- Karim S, Brennan K, Nanji S, Berry SR, Booth CM. Association between Prognosis and Tumor Laterality in Early-Stage Colon Cancer. JAMA Oncol 2017; 3(10):1386-92. [DOI] [PMID] [PMCID]
13. 13- Liang WY, Wang YC, Hsu CY, Yang SH. Staging of colorectal cancers based on elastic lamina invasion. Hum Pathol 2019; 85:44-9. [] [PMID]
14. 14- Allemani C, Matsuda T, Di Carlo V, Harewood R, Matz M, Niksic M, et al. Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. Lancet 2018; 391(10125):1023-75. [DOI] [PMID] [PMCID]
15. 15- Engel C, Vasen HF, Seppälä T, Aretz S, Bigirwamungu-Bargeman M, de Boer SY, et al. No Difference in Colorectal Cancer Incidence or Stage at Detection by Colonoscopy among 3 Countries with Different Lynch Syndrome Surveillance Policies. Gastroenterology 2018; 155(5):1400-9. [DOI] [PMID]
16. 16- Carr PR, Weigl K, Jansen L, Walter V, Erben V, Chang-Claude J, et al. Healthy Lifestyle Factors Associated with Lower Risk of Colorectal Cancer Irrespective of Genetic Risk. Gastroenterology 2018; 155(6):1805-15. [DOI] [PMID] [PMCID]
17. 17- Wang X, Mao M, Xu G, Lin F, Sun P, Baklaushev VP, et al. The incidence, associated factors, and predictive nomogram for early death in stage IV colorectal cancer. Int J Colorectal Dis 2019; 34(7):1189-201. [DOI] [PMID]
18. 18- Rim CH, Kim CY, Yang DS, Yoon WS. Clinical Significance of Gender and Body Mass Index in Asian Patients with Colorectal Cancer. J Cancer 2019; 10(3):682-8. [DOI] [PMID] [PMCID]
19. 19- Holme Ø, Løberg M, Kalager M, Bretthauer M, Hernán MA, Aas E, et al. Long-Term Effectiveness of Sigmoidoscopy Screening on Colorectal Cancer Incidence and Mortality in Women and Men: A Randomized Trial. Ann Intern Med 2018; 168(11):775-82. [DOI] [PMID] [PMCID]
20. 20- Peterse EFP, Meester RGS, Siegel RL, Chen JC, Dwyer A, Ahnen DJ, et al. The impact of the rising colorectal cancer incidence in young adults on the optimal age to start screening: microsimulation analysis I to inform the American Cancer Society colorectal cancer screening guideline. Cancer 2018; 124(14):2964-73. [DOI] [PMID] [PMCID]
21. 21- Hayes L, Forrest L, Adams J, Hidajat M, Ben-Shlomo Y, White M, et al. Age-related inequalities in colon cancer treatment persist over time: a population-based analysis. J Epidemiol Community Health 2019; 73(1):34-41. [DOI] [PMID]
22. 22- Sung JJY, Chiu HM, Jung KW, Jun JK, Sekiguchi M, Matsuda T, et al. Increasing Trend in Young-Onset Colorectal Cancer in Asia: More Cancers in Men and More Rectal Cancers. Am J Gastroenterol 2019; 114(2):322-9. [DOI] [PMID]
23. 23- Ansa BE, Coughlin SS, Alema-Mensah E, Smith SA. Evaluation of Colorectal Cancer Incidence Trends in the United States (2000–2014). J Clin Med 2018; 7(2):22. [DOI] [PMID] [PMCID]
24. 24- McSorley ST, Black DH, Horgan PG, McMillan DC. The relationship between tumour stage, systemic inflammation, body composition and survival in patients with colorectal cancer. Clin Nutr 2018; 37(4):1279-85.‏ [DOI] [PMID]
25. 25- Yin Y, Wang T, Zhang P, Li C, Yang W, Lin Y, et al. A Novel Model Predicts Postoperative Pathology of Colorectal High-Grade Intraepithelial Neoplasia. J Surg Res 2019; 240:104-8.‏ [DOI] [PMID]
26. 26- Wang CB, Shahjehan F, Merchea A, Li Z, Bekaii-Saab TS, Grothey A, et al. Impact of Tumor Location and Variables Associated with Overall Survival in Patients with Colorectal Cancer: A Mayo Clinic Colon and Rectal Cancer Registry Study. Front Oncol 2019; 9:76. [DOI] [PMID] [PMCID]
27. 27- Fields AC, Lu P, Vierra BM, Hu F, Irani J, Bleday R, et al. Survival in Patients with High-Grade Colorectal Neuroendocrine Carcinomas: The Role of Surgery and Chemotherapy. Ann Surg Oncol 2019; 26(4):1127-33. [DOI] [PMID] [PMCID]
28. 28- Kim S, Lee SC, Skinner CS, Brown CJ, Balentine CJ. A Surgeon’s Guide to Treating Older Patients with Colorectal Cancer. Curr Colorectal Cancer Rep 2019; 15(1):1-7. [DOI] [PMID] [PMCID]
29. 29- Vallance AE, Young AL, Kuryba A, Braun M, Hill J, Jayne DG, et al. The impact of advancing age on incidence of hepatectomy and post-operative outcomes in patients with colorectal cancer liver metastases: a population-based cohort study. HPB (Oxford) 2019; 21(2):167-74. [DOI] [PMID]
30. 30- Fu J, Ruan H, Zheng H, Cai C, Zhou S, Wang Q, et al. Impact of old age on resectable colorectal cancer outcomes. PeerJ 2019; 7:e6350. [DOI] [PMID] [PMCID]
31. 31- Rogers HL, Dumenci L, Epstein RM, Siminoff LA. Impact of Patient Gender and Race and Physician Communication on Colorectal Cancer Diagnostic Visits in Primary Care. J Womens Health (Larchmt) 2019; 28(5):612-20. [DOI] [PMID] [PMCID]

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2022 CC BY-NC 4.0 | Journal of Occupational Health and Epidemiology

Designed & Developed by : Yektaweb